Author

C. W. Farnsworth

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 3 Approach:experimental assay· 2 Approach:statistical model· 1

Frequent Co-Authors

M. S. Diamond· 2 shared A. B. Moyle· 1 shared A. H. Ellebedy· 1 shared A. Hachim· 1 shared A. J. Qavi· 1 shared A. J. Schmitz· 1 shared A. J. Sturtz· 1 shared A. M. Gronowski· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. S. Diamond

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 Omicron boosting induces de novo B cell response in humans

W. B. Alsoussi, S. K. Malladi, J. Q. Zhou, Z. Liu, B. Ying, W. Kim, A. J. Schmitz, T. Lei, S. C. Horvath, A. J. Sturtz, K. M. McIntire, B. Evavold, F. Han, S. M. Scheaffer, I. F. Fox, , A. H. Ellebedy

This study shows that SARS-CoV-2 boosting induces GC B cell responses and that Omicron-based vaccines can elicit novel epitope-specific antibodies despite antigenic imprinting.

Nature · Apr 3, 2023Peer-reviewedImmunology

Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain

C. Wu, A. J. Qavi, A. Hachim, N. Kavian, A. R. Cole, A. B. Moyle, N. D. Wagner, J. Sweeney-Gibbons, H. W. Rohrs, M. L. Gross, J. S. M. Peiris, C. F. Basler, C. W. Farnsworth, S. A. Valkenburg, G. K. Amarasinghe, D. W. Leung

This study characterizes the SARS-CoV-2 N protein, identifying domain-specific functions and highlighting the C-terminal domain's immunogenicity for diagnostic applications.

bioRxiv · Nov 30, 2020Biochemistry

Association between neutralizing antibodies to SARS-CoV-2 and commercial serological assays

M. S. Tang, J. B. Case, C. E. Franks, R. E. Chen, N. W. Anderson, J. P. Henderson, M. S. Diamond, A. M. Gronowski, C. W. Farnsworth

This study evaluates the association between SARS-CoV-2 neutralizing antibodies and results from three commercial serological assays, finding moderate correlations and varying agreement rates.

bioRxiv · Jul 1, 2020Immunology